Mito-AUTAC Technology Development

Mito-AUTAC technology is a mitochondria-oriented Autophagy-Targeting Chimera (AUTAC) strategy designed to induce selective mitochondrial clearance through the autophagy-lysosome pathway. A typical Mito-AUTAC molecule contains three functional elements: a mitochondria-targeting warhead that directs the molecule to mitochondrial membranes or mitochondrial-associated proteins, an autophagy-recruiting degradation tag that promotes autophagy-recognition signals such as K63-linked ubiquitination, and a linker that controls distance, flexibility, polarity, and spatial orientation between the two functional modules. The effectiveness of a Mito-AUTAC design depends on mitochondrial localization, tag exposure, linker geometry, cell model compatibility, and the ability to distinguish true mitophagy from nonspecific mitochondrial stress.

BOC Sciences provides integrated Mito-AUTAC technology development services for pharmaceutical, biotechnology, academic, and CRO research teams seeking to explore mitochondrial degradation beyond conventional small-molecule modulation. Our support covers mitochondrial target feasibility assessment, warhead and degradation tag design, linker engineering, Mito-AUTAC synthesis, mitophagy assay development, K63-linked ubiquitination analysis, mitochondrial function profiling, phenotypic model validation, and iterative optimization. By connecting chemistry, mitochondrial biology, and mechanism-focused evaluation, we help clients build Mito-AUTAC programs with clearer design logic and more actionable research data.

BOC Sciences' Comprehensive Mito-AUTAC Technology Development Services

Mitochondrial Target Assessment and Feasibility Analysis

The first step in Mito-AUTAC development is to determine whether the selected mitochondrial target, damaged organelle population, or disease-relevant mitochondrial phenotype is suitable for selective autophagy-mediated clearance. BOC Sciences evaluates target accessibility, mitochondrial localization, pathway context, cellular readout feasibility, and early biological risks to help clients define a technically sound development strategy.

• Mitochondrial dysfunction target screening: evaluation of disease-associated mitochondrial proteins, damaged mitochondrial fragments, organelle accessibility, biological relevance, and autophagic clearance potential
• Mitophagy pathway compatibility analysis: assessment of baseline autophagy level, mitochondrial fragmentation characteristics, and Parkin-dependent or Parkin-independent pathway activity in selected cell models
• Early risk mapping: evaluation of energy crisis risk caused by excessive mitochondrial clearance, off-target mitochondrial toxicity, and feasibility of mitochondrial readout design

Mitochondria-Targeting Warhead Design

Mito-AUTAC molecules require a mitochondrial-targeting warhead that can direct the degrader to the intended mitochondrial membrane compartment or mitochondrial protein environment. We support the design, screening, derivatization, and validation of mitochondrial ligands while ensuring that AUTAC conjugation does not compromise organelle targeting, membrane penetration, or target-binding activity.

• Mitochondrial membrane-targeting ligand screening: design or screening of small-molecule ligands targeting the translocase of the outer mitochondrial membrane/translocase of the inner mitochondrial membrane (TOM/TIM) complexes, inner mitochondrial membrane, or matrix-associated proteins
• Derivatization of known mitochondrial ligands: AUTAC-compatible modification of triphenylphosphonium (TPP⁺), indole derivatives such as 2-phenylindole used in AUTAC4-inspired designs, and other mitochondria-associated scaffolds
• Ligand–mitochondria binding validation: confirmation of mitochondrial targeting specificity through co-localization imaging, mitochondrial fractionation, and subcellular distribution analysis

Autophagy-Recruiting Degradation Tag and Linker Engineering

The autophagy-recruiting degradation tag and linker architecture determine whether a Mito-AUTAC molecule can efficiently generate autophagy-recognition signals and support mitophagy-associated clearance. BOC Sciences optimizes tag structure, linker length, linker flexibility, conjugation site, molecular polarity, and cLogP to balance mitochondrial membrane penetration, K63-linked ubiquitination induction, and autophagosome recruitment efficiency.

• Autophagy-recruiting degradation tag optimization: selection and modification of 8-nitro-cyclic guanosine monophosphate (8-nitro-cGMP)-inspired degradation tags or related functional motifs to improve K63-linked ubiquitination induction and autophagy pathway engagement
• Linker length and flexibility design: linker engineering adapted to the double-membrane structure of mitochondria to balance membrane penetration and autophagosome recruitment
• Linker attachment site analysis: identification of optimal conjugation sites between the mitochondrial-targeting warhead and tag-displaying domain to reduce steric hindrance
• Molecular polarity and cLogP modulation: optimization of lipophilicity and intracellular exposure to support mitochondrial membrane penetration and maintain cellular activity

Mitophagy Functional Validation and Mechanism Confirmation

Mito-AUTAC activity must be distinguished from nonspecific mitochondrial damage, general cytotoxic stress, or impaired mitochondrial biogenesis. We provide multi-readout validation workflows that integrate mitochondrial localization, membrane-potential analysis, K63-linked ubiquitination, autophagy marker profiling, mitochondrial clearance quantification, and pathway rescue studies.

• Mitochondrial uptake and subcellular localization: confirmation of mitochondrial enrichment through MitoTracker co-staining, subcellular imaging, and transmission electron microscopy
• Mitochondrial fragmentation and membrane-potential detection: assessment of ΔΨ_m using JC-1 or TMRE assays, together with ROS profiling
• K63-linked ubiquitination and autophagy marker analysis: Western blot analysis of K63-Ub, LC3-II, and p62/SQSTM1 accumulation to confirm autophagy-associated pathway engagement
• Mitochondrial mass clearance quantification: flow cytometry, mt-mKeima-based mitophagy analysis, and immunofluorescence quantification of fragmented mitochondrial clearance
• Rescue experiments and pathway inhibition: use of autophagy inhibitors such as Bafilomycin A1 and 3-methyladenine (3-MA), or lysosome pathway modulators, to confirm mechanism specificity

Phenotypic Function and Disease-Relevant Model Validation

BOC Sciences supports phenotype-focused Mito-AUTAC validation to determine whether mitochondrial clearance leads to functional improvement, energy recovery, apoptosis reduction, or selective vulnerability in disease-relevant cellular models.

• Acute mitochondrial damage rescue experiments: evaluation of Mito-AUTAC effects in CCCP- or Rotenone-induced mitochondrial damage models, including mitochondrial stress recovery and cell-state improvement
• ATP recovery and apoptosis inhibition: detection of ATP, cytochrome c release, cleaved caspase-3, and related rescue phenotypes
• Disease-relevant cellular model validation: testing in Down syndrome (DS) fibroblasts, neurodegenerative disease induced pluripotent stem cell (iPSC)-derived models, and other mitochondrial dysfunction systems
• Anti-tumor mitochondrial vulnerability exploration: assessment of differential mitochondrial stress response and selective killing potential in tumor models with metabolic reprogramming

Developability Assessment and Research Translation Support

Because Mito-AUTAC molecules often contain mitochondria-targeting motifs, degradation tags, and linkers within one structure, their physicochemical properties and mitochondrial selectivity require careful optimization. BOC Sciences supports developability-focused evaluation to improve compound behavior, reduce off-target organelle effects, and generate decision-ready data for further research optimization.

• Physicochemical property and permeability optimization: evaluation of solubility, LogP, cellular permeability, and strategies to address low exposure caused by excessive polarity
• Off-target effect and mitochondrial selectivity assessment: analysis of mitochondrial DNA content, effects on non-target organelles, and excessive autophagy risk
• In vivo PK/PD and distribution research: design of animal research studies to evaluate tissue distribution, mitochondrial targeting efficiency, exposure–response relationships, and pharmacodynamic readouts

Our Solutions for Mito-AUTAC Development Challenges

Mito-AUTAC projects require more than simply connecting a mitochondrial ligand and an AUTAC tag. Productive development depends on organelle biology, mitochondrial state, linker geometry, autophagy competence, assay design, and careful interpretation of mitochondrial function data. BOC Sciences provides integrated solutions that connect molecular design with mechanism-driven validation.

Solution for Mitochondrial Targeting Feasibility

A frequent barrier is that researchers may know the mitochondrial phenotype they want to study, but not whether it can be addressed by Mito-AUTAC chemistry. We analyze mitochondrial localization, membrane accessibility, basal mitophagy activity, stress sensitivity, mitochondrial marker suitability, and cell model robustness. This helps clients avoid weak project starts and focus on designs with measurable, mechanism-relevant endpoints.

Solution for Ligand, Tag, and Linker Integration

In Mito-AUTAC design, a strong mitochondrial ligand does not guarantee productive mitophagy. The degradation tag must be positioned so that mitochondrial-associated ubiquitination and autophagy receptor engagement can occur efficiently. We generate focused design matrices covering ligand exit vectors, guanine-tag placement, linker length, polarity, and rigidity, then prioritize structures based on both chemical feasibility and expected biological performance.

Solution for Mitophagy Assay Development

Mitochondrial clearance can be difficult to interpret if only one readout is used. Our solution is to build layered assay systems that combine mitochondrial protein markers such as TOM20, VDAC1, and COX IV with LC3 association, LAMP1 co-localization, autophagy flux markers, and mitochondrial function assays. This multi-readout approach helps distinguish selective mitophagy from mitochondrial toxicity or reduced mitochondrial biogenesis.

Solution for Data Interpretation and Optimization

Mito-AUTAC datasets often include complex relationships among dose, exposure time, mitochondrial stress, autophagy flux, and cell response. We interpret degradation kinetics, D_max, DC₅₀, mitochondrial function, pathway controls, and compound structure together. This enables clients to decide whether to optimize the targeting ligand, linker, degradation tag, assay window, or cellular model.

Our Mito-AUTAC Solutions Support Diverse R&D Organizations

End-to-End Mito-AUTAC Technology Development Workflow

Advantages of Mito-AUTAC Technology

Targets Mitochondrial Quality Control

Mito-AUTAC technology enables researchers to investigate mitochondrial clearance directly, offering a targeted approach to study mitophagy, organelle turnover, and mitochondrial stress response.

Expands Beyond Proteasomal Degradation

Because mitochondria are large organelles rather than soluble proteasome substrates, Mito-AUTAC research expands degradation strategy into autophagy-lysosome biology and organelle-selective clearance.

Supports Mechanistic Mitophagy Studies

Mito-AUTAC designs can be evaluated through K63-linked ubiquitination, autophagy receptor recruitment, LC3 association, lysosomal delivery, and mitochondrial function profiling.

Enables Structure-Guided Optimization

Systematic changes to mitochondrial ligand, linker, and degradation tag architecture allow clients to understand how chemical structure influences organelle localization and mitophagy outcome.

Applications Supported by Our Mito-AUTAC Technology Platform

Client Success Stories: Mito-AUTAC Technology Development

Why Choose BOC Sciences for Your Mito-AUTAC Project?

Integrated Mito-AUTAC Development Support

We provide coordinated support across mitochondrial target assessment, ligand strategy, molecular design, custom synthesis, mitophagy assays, and optimization.

Deep Autophagy-Based Degrader Expertise

Our team understands the unique design logic of AUTAC and mitochondria-focused degradation, including tag placement, linker architecture, and autophagy pathway validation.

Mechanism-Focused Validation

We design studies that connect K63-linked ubiquitination, autophagy receptor engagement, lysosomal delivery, mitochondrial marker reduction, and functional readouts.

Flexible Modular Service Models

Clients can access individual modules, such as linker optimization or mitophagy assay development, or request end-to-end Mito-AUTAC development from concept to optimized analog series.

Data-Driven Design Iteration

We connect chemistry and biology data to refine mitochondrial ligands, AUTAC tags, linker properties, cell models, and assay conditions through rational optimization cycles.

Clear Reporting and Decision Support

We provide organized experimental data, practical interpretation, and clear recommendations to support the next stage of Mito-AUTAC design, screening, or validation.